Intoxications Amenable to Extracorporeal Removal

被引：6

作者：

Winchester, James F. ^{[1
]}

Harbord, Nikolas B. ^{[1
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Div Nephrol & Hypertens, New York, NY 10003 USA

来源：

ADVANCES IN CHRONIC KIDNEY DISEASE | 2011年 / 18卷 / 03期

关键词：

Toxins; Dialysis; Hemoperfusion; Pharmacokinetics; Toxokinetics; HEMOPERFUSION; HEMODIALYSIS; ELIMINATION; FOMEPIZOLE; DIALYSIS; EFFICACY; POISONS; FAILURE; PATIENT; KIDNEY;

D O I：

10.1053/j.ackd.2010.10.007

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Extracorporeal removal of drugs was first attempted in 1913, by John Jacob Abel. Previously known to be a rarity, dialysis and to a lesser extent hemoperfusion have now become obvious tools for nephrologists in treating life-threatening cases of poisoning. Moreover, for dialysis patients, dialysis along with chelation therapy for removal of aluminum, once known to be common in the United States, is resurging in some countries. This article will discuss the principles of drug removal, the indications for dialysis, and give a brief outline of poisons amenable to dialysis. (C) 2011 by the National Kidney Foundation, Inc. All rights reserved.

引用

页码：167 / 171

页数：5

共 21 条

[1] Five years of poisons information on the internet: the UK experience of TOXBASE [J].

Bateman, D. N. ;

Good, A. M. .

EMERGENCY MEDICINE JOURNAL, 2006, 23 (08) :614-617

[2] Fomepizole for the treatment of ethylene glycol poisoning [J].

Brent, J ;

McMartin, K ;

Phillips, S ;

Burkhart, KK ;

Donovan, JW ;

Wells, M ;

Kulig, K .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (11) :832-838

[3] 2008 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th Annual Report [J].

Bronstein, Alvin C. ;

Spyker, Daniel A. ;

Cantilena, Louis R., Jr. ;

Green, Jody L. ;

Rumack, Barry H. ;

Giffin, Sandra L. .

CLINICAL TOXICOLOGY, 2009, 47 (10) :911-1084

[4]

HANSEN HE, 1978, Q J MED, V47, P123

[5] Methanol and formate kinetics during treatment with fomepizole [J].

Hovda, KE ;

Andersson, KS ;

Urdal, P ;

Jacobsen, D .

CLINICAL TOXICOLOGY, 2005, 43 (04) :221-227

[6] XAD-4 RESIN HEMOPERFUSION FOR DIGITOXIC PATIENTS WITH RENAL-FAILURE [J].

HOY, WE ;

GIBSON, TP ;

RIVERO, AJ ;

JAIN, VK ;

TALLEY, TT ;

BAYER, RM ;

MONTONDO, DF ;

FREEMAN, RB .

KIDNEY INTERNATIONAL, 1983, 23 (01) :79-82

[7]

Kalabalikis P, 2001, VET HUM TOXICOL, V43, P31

[8] Successful treatment of digoxin intoxication by haemoperfusion with specific columns for β2-microgloblin-adsorption (Lixelle™) in a maintenance haemodialysis patient [J].

Kaneko, T ;

Kudo, M ;

Okumura, T ;

Kasiwagi, T ;

Turuoka, S ;

Simizu, M ;

Iino, Y ;

Katayama, Y .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (01) :195-196

[9] Comparison between Kidney and Hemoperfusion for Paraquat Elimination [J].

Kang, Moon-Soo ;

Gil, Hyo-Wook ;

Yang, Jong-Oh ;

Lee, Eun-Young ;

Hong, Sae-Yong .

JOURNAL OF KOREAN MEDICAL SCIENCE, 2009, 24 :S156-S160

[10] Early Molecular Adsorbents Recirculating System Treatment of Amanita Mushroom Poisoning [J].

Kantola, Taru ;

Kantola, Teemu ;

Koivusalo, Anna-Maria ;

Hockerstedt, Krister ;

Isoniemi, Helena .

THERAPEUTIC APHERESIS AND DIALYSIS, 2009, 13 (05) :399-403

← 1 2 3 →